- Home
- CRON vs SGP Comparison
CRON vs SGP Comparison
Compare CRON & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRON | SGP |
|---|---|---|
| Founded | N/A | 2019 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 985.8M | 932.9M |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | CRON | SGP |
|---|---|---|
| Price | $2.80 | $24.00 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $45.00 |
| AVG Volume (30 Days) | ★ 2.0M | 55.7K |
| Earning Date | 05-11-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.04 | N/A |
| Revenue | ★ $146,587,000.00 | N/A |
| Revenue This Year | $26.34 | N/A |
| Revenue Next Year | $15.53 | N/A |
| P/E Ratio | $67.78 | ★ N/A |
| Revenue Growth | ★ 24.63 | N/A |
| 52 Week Low | $1.84 | $20.15 |
| 52 Week High | $3.43 | $30.56 |
Technical Indicators
Market Signals| Indicator | CRON | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 60.29 | 50.07 |
| Support Level | $2.46 | $20.95 |
| Resistance Level | $3.26 | $26.55 |
| Average True Range (ATR) | 0.12 | 1.49 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 58.33 | 62.24 |
Price Performance
Historical ComparisonAbout CRON Cronos Group Inc.
Cronos Group Inc is a cannabinoid company committed to building disruptive intellectual property by advancing cannabis research, technology, and product development. With a passion for responsibly elevating the consumer experience, the company is building an iconic brand portfolio. Its diverse international brand portfolio includes Spinach, PEACE NATURALS, LIT, and Lord Jones. The company operates in Canada, Israel, and other countries, with the majority of its revenue generated from Canada.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.